REFERENCES
- Physicians Desk Reference, 49th ed. Montvale, NJ: Medical Economics Data Production Company; 1995:824–827.
- Davidson J: Seizures and buproprion: A review. J Clin Psy-chiatry 1989; 50:256–261
- Johnston JA, Kineberry CG, Ascher JA, Davidson J, Khayral-lah MA, Feighner JP, Stark 13; A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry 1991; 52:450–456
- Preskom SH: Antidepressant response and plasma concentra-tions of bupropion. J Clin Psychiatry 1983; 44(5):137–139
- Haykal RD, Akiskal HS: Bupropion as a promising approach to rapid recycling bipolar II patients. J Clin Psychiatry 1990; 51:450–455
- Golden RN, DeVane CL, Laizure SC, Rudorfer MV, Sherer MA, Potter WZ: Bupropion in depression. II. The role of me-tabolites in clinical outcome. Arch Gen Psychiatry 1988; 45:145–149
- Preskom SH: Update on clinical aspects of cytochrome P-450 mixed function oxidases. Curr Affect Illness 1995; 14:5–13
- Ketter TA, Barnett J, Schroeder DH, Hinton ML, Chao J, Post RM: Carbamazepine induces bupropion metabolism. Pa-per presentation, American Psychiatric Association Annual Meeting, Washington D.C; May 7,1992
- Goodnick PJ: Plasma levels and acute response to bupropion. Am J Psychiatry 1992; 149:399–402
- Preskorn SH: Should bupropion dosage be adjusted based upon therapeutic drug monitering? Psychopharmacol Bull 1991; 27:637–643
- Popli A1 Baldessarini RJ, Cole JO: Interaction of serotonin reuptake inhibitors with tricyclic antidepressants. Arch Gen Psychiatry 1994; 51;666–667
- Toth P, Frankenburg FR: Clozapine and seizures: A review. Can J Psychiatry 1994; 39:236–238.